デフォルト表紙
市場調査レポート
商品コード
1461271

女性向けヘルステック市場:2024-2034年

Female Health Tech Market Report 2024-2034

出版日: | 発行: Visiongain | ページ情報: 英文 284 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=198.54円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

女性向けヘルステック市場:2024-2034年
出版日: 2024年04月05日
発行: Visiongain
ページ情報: 英文 284 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の女性向けヘルステックの市場規模は、2034年にかけてCAGR 9.6%で成長すると予測されています。

女性の健康に対する認識と注目の高まり:

長い間見過ごされてきた女性特有のヘルスケアニーズが注目されはじめ、女性の健康に対する認識と焦点が一変しました。これまで女性の健康問題はしばしば見過ごされたり、ヘルスケアという広い文脈の中で一般化されたりしてきましたが、ヘルスケア専門家、研究者、アドボカシー団体、政策立案者の一致団結した努力により、この状況は大きく変わりつつあります。研究イニシアティブは、女性特有の状態を掘り下げ、生殖に関する健康、ホルモンの変動、子宮内膜症や多嚢胞性卵巣症候群 (PCOS) などの病気の複雑さを解明してきました。同時に、教育キャンペーンは、女性の健康を取り巻くタブーを取り払い、開かれた対話を促進し、女性が自らの幸福を擁護する力を与えることを目指してきました。公衆衛生キャンペーンは、妊産婦死亡率、乳癌の認知度、避妊へのアクセスといった重要な問題にスポットライトを当て、的を絞った介入への緊急性を高めてきました。さらに、アドボカシー運動は政策変更を促し、女性の健康が公衆衛生課題の基本的な側面であるとの認識を高めることにつながっています。このような意識の高まりは、ヘルスケアに対するより包括的なアプローチを促進しただけでなく、月経追跡のためのウェアラブルデバイスから、パーソナライズされた健康洞察のためのAIを搭載したプラットフォームまで、様々なソリューションによって、女性向けヘルステックにおけるイノベーションを推進しました。全体として、女性の健康に対する認識と注目の高まりは、公平なヘルスケア提供への極めて重要なシフトと、生涯にわたる女性の多様なニーズへの深い理解を意味します。

患者ケアにおける技術の進歩:

女性向けヘルステックにおける技術の進歩は、女性特有のニーズや経験に対応するよう調整された革新的なソリューションを提供し、女性のヘルスケアの状況を一変させました。こうした進歩は、生殖に関する健康から更年期管理まで幅広い分野に及び、さまざまな技術分野の飛躍的進歩によって可能となっています。

スマートウォッチやフィットネストラッカーなどのウェアラブルデバイスは、女性が月経周期をモニターし、受胎可能期間を追跡し、全体的な健康とウェルネスを管理するための強力なツールとして登場しました。これらのデバイスはセンサーとアルゴリズムを活用して生理的パラメーターのデータを収集し、ユーザーに生殖に関する健康についての貴重な洞察を提供し、避妊、受胎計画、月経周期管理について十分な情報に基づいた決定を下すのに役立っています。

モバイルアプリケーションもまた、女性が自分の健康を管理できるようにする上で重要な役割を果たしています。これらのアプリは、月経追跡、排卵予測、妊娠モニタリング、子宮内膜症やPCOSなどの症状管理など、多様な機能を提供しています。健康情報をデジタル化し、パーソナライズされた推奨を提供することで、これらのアプリは女性が自分の健康と幸福の管理に積極的に参加することを可能にします。

遠隔医療プラットフォームは、特に医療が行き届いていない地域や移動に制約のある女性のヘルスケアサービスへのアクセスを拡大してきました。これらのプラットフォームは、ヘルスケア提供者との遠隔相談を容易にし、女性が自宅にいながらアドバイスを求めたり、診断を受けたり、治療にアクセスしたりすることを可能にします。これは、対面でのヘルスケアサービスが限られていたCOVID-19の流行時に特に価値があることが証明されています。

当レポートでは、世界の女性向けヘルステックの市場を調査し、市場概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 レポートの概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主要調査結果
  • 市場力学
    • 市場推進要因
    • 市場抑制要因
    • 市場機会
  • COVID-19の影響分析
  • ポーターのファイブフォース分析
  • PEST分析

第4章 女性向けヘルステック市場:製品タイプ別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 消費者製品
  • デバイス (ウェアラブル、ハードウェア)
  • ソフトウェア (アプリ)
  • 診断
  • デジタルプラットフォーム
  • 医薬品、ビタミン、サプリメント
  • サービス
  • 遠隔医療
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第5章 女性向けヘルステック市場:用途別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 妊娠と看護
  • 生殖保健と避妊
  • 月経の健康
  • 一般的な健康
  • 骨盤と子宮の健康
  • 性の健康
  • 女性のウェルネス
  • 更年期ケア
  • 長寿
  • メンタルヘルス
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第6章 女性向けヘルステック市場:地域別

  • 主要調査結果
  • 市場規模の推移・予測

第7章 北米の女性向けヘルステック市場の分析

第8章 欧州の女性向けヘルステック市場の分析

第9章 アジア太平洋の女性向けヘルステック市場の分析

第10章 ラテンアメリカの女性向けヘルステック市場の分析

第11章 中東・アフリカの女性向けヘルステック市場の分析

第12章 企業プロファイル

  • 競合情勢
  • 戦略的展望
  • Athena Feminine Technologies, Inc.
  • Bloomlife, Inc.
  • Elvie (Chiaro Technology Limited)
  • HeraMed Ltd
  • iSono Health, Inc.
  • Minerva Surgical, Inc.
  • Nuvo, Inc.
  • Prelude Fertility, Inc.
  • Sera Prognostics
  • Univfy, Inc.
  • Totohealth Limited

第13章 総論・提言

  • Visiongainによる総論
  • 推奨事項
図表

List of Tables

  • Table 1 Female Health Tech Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
  • Table 2 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 7 Consumer Products Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 8 Devices (Wearables, hardware) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 9 Software (Apps) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 10 Diagnostics Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 11 Digital Platform Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 12 Drugs, Vitamins & Supplements Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 13 Services Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 14 Telehealth Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 15 Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 16 Pregnancy and Nursing Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 17 Reproductive Health and Contraception Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 18 Menstrual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 19 General Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 20 Pelvic and Uterine Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 21 Sexual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 22 Women's Wellness Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 23 Menopause Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 24 Longevity Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 25 Mental Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 26 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 27 North America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 28 North America Female Health Tech Market Product Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 29 North America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 30 U.S. Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 31 Canada Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 32 Europe Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 33 Europe Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 34 Europe Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 35 Germany Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 36 France Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 37 UK Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 38 Italy Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 39 Spain Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 40 Russia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 41 Poland Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 42 Belgium Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 43 Rest of Europe Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 44 Asia Pacific Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 45 Asia Pacific Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 46 Asia Pacific Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 47 Japan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 48 China Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 49 India Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 50 Australia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 51 South Korea Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 52 Singapore Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 53 Taiwan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 54 Rest of Asia Pacific Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 55 Latin America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 56 Latin America Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 57 Latin America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 58 Brazil Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 59 Mexico Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 60 Argentina Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 61 Colombia Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 62 Rest of Latin America Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 63 MEA Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 64 MEA Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 65 MEA Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 66 GCC Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 67 South Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 68 Rest of MEA Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
  • Table 69 Strategic Outlook
  • Table 70 Athena Feminine Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 71 Athena Feminine Technologies, Inc.: Product Benchmarking
  • Table 72 Athena Feminine Technologies, Inc.: Strategic Outlook
  • Table 73 Bloomlife, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 74 Bloomlife, Inc.: Product Benchmarking
  • Table 75 Bloomlife, Inc.: Strategic Outlook
  • Table 76 Elvie (Chiaro Technology Limited) : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 77 Elvie (Chiaro Technology Limited): Product Benchmarking
  • Table 78 Elvie (Chiaro Technology Limited): Strategic Outlook
  • Table 79 HeraMed Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 80 HeraMed Ltd: Product Benchmarking
  • Table 81 HeraMed Ltd.: Strategic Outlook
  • Table 82 iSono Health, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 83 iSono Health, Inc.: Product Benchmarking
  • Table 84 iSono Health, Inc.: Strategic Outlook
  • Table 85 Minerva Surgical, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 86 Minerva Surgical, Inc.: Product Benchmarking
  • Table 87 Minerva Surgical, Inc.: Strategic Outlook
  • Table 88 Nuvo, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 Nuvo, Inc.: Product Benchmarking
  • Table 90 Nuvo, Inc.: Strategic Outlook
  • Table 91 Prelude Fertility, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 92 Prelude Fertility, Inc.: Product Benchmarking
  • Table 93 Prelude Fertility, Inc.: Strategic Outlook
  • Table 94 Sera Prognostics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 95 Sera Prognostics: Product Benchmarking
  • Table 96 Sera Prognostics: Strategic Outlook
  • Table 97 Univfy, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 Univfy Inc.: Product Benchmarking
  • Table 99 Univfy Inc.: Strategic Outlook
  • Table 100 Totohealth Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 101 Totohealth Limited.: Product Benchmarking

List of Figures

  • Figure 1 Female Health Tech Market Segmentation
  • Figure 2 Female Health Tech Market by Product: Market Attractiveness Index
  • Figure 3 Female Health Tech Market by Application: Market Attractiveness Index
  • Figure 4 Female Health Tech Market Attractiveness Index by Region
  • Figure 5 Female Health Tech Market: Market Dynamics
  • Figure 6 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): "V" Shaped Recovery
  • Figure 7 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): "U" Shaped Recovery
  • Figure 8 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): "W" Shaped Recovery
  • Figure 9 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): "L" Shaped Recovery
  • Figure 10 Female Health Tech Market: Porter's Five Forces Analysis
  • Figure 11 Female Health Tech Market: PEST Analysis
  • Figure 12 Female Health Tech Market by Product Types: Market Attractiveness Index
  • Figure 13 Female Health Tech Market Forecast by Product Types, 2024-2034 (US$ Billion, AGR %)
  • Figure 14 Female Health Tech Market Share Forecast by Product Types, 2024, 2029, 2034 (%)
  • Figure 15 Consumer Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 16 Consumer Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 17 Devices (Wearables, hardware) Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 18 Devices (Wearables, hardware) Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 19 Software (Apps) Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 20 Software (Apps) Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 21 Diagnostics Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 22 Diagnostics Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 23 Digital Platform Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 24 Digital Platform Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 25 Drugs, Vitamins & Supplements Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 26 Drugs, Vitamins & Supplements Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 27 Services Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 28 Services Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 29 Telehealth Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 30 Telehealth Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 31 Female Health Tech Market by Application: Market Attractiveness Index
  • Figure 32 Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 33 Female Health Tech Market Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 34 Pregnancy and Nursing Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 35 Pregnancy and Nursing Care Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 36 Reproductive Health and Contraception Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 37 Reproductive Health and Contraception Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 38 Menstrual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 39 Menstrual Health Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 40 General Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 41 General Healthcare Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 42 Pelvic and Uterine Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 43 Pelvic and Uterine Healthcare Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 44 Sexual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 45 Sexual Health Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 46 Women's Wellness Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 47 Women's Wellness Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 48 Menopause Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 49 Menopause Care Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 50 Longevity Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 51 Longevity Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 52 Mental Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 53 Mental Health Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 54 Female Health Tech Market Forecast by Region 2024 and 2034 (Revenue, CAGR %)
  • Figure 55 Female Health Tech Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 56 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 57 North America Female Health Tech Market Attractiveness Index
  • Figure 58 North America Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 59 North America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 60 North America Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 61 North America Female Health Tech Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 62 North America Female Health Tech Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 63 North America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 64 North America Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 65 U.S. Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 66 Canada Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 67 Europe Female Health Tech Market Attractiveness Index
  • Figure 68 Europe Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 69 Europe Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 70 Europe Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 71 Europe Female Health Tech Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 72 Europe Female Health Tech Market Share Forecast by Product Type, 2024 & 2034 (%)
  • Figure 73 Europe Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 74 Europe Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 75 Germany Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 76 France Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 77 UK Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 78 Italy Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 79 Spain Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 80 Russia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 81 Poland Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 82 Belgium Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 83 Rest of Europe Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 84 Asia Pacific Female Health Tech Market Attractiveness Index
  • Figure 85 Asia Pacific Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 86 Asia Pacific Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 87 Asia Pacific Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 88 Asia Pacific Female Health Tech Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 89 Asia Pacific Female Health Tech Market Share Forecast by Product Type, 2024 & 2034 (%)
  • Figure 90 Asia Pacific Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 91 Asia Pacific Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 92 Japan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 93 China Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 94 India Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 95 Australia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 96 South Korea Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 97 Singapore Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 98 Taiwan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 99 Rest of Asia Pacific Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 100 Latin America Female Health Tech Market Attractiveness Index
  • Figure 101 Latin America Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 102 Latin America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 103 Latin America Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 104 Latin America Female Health Tech Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 105 Latin America Female Health Tech Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 106 Latin America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 107 Latin America Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 108 Brazil Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 109 Mexico Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 110 Argentina Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 111 Colombia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 112 Rest of Latin America Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 113 MEA Female Health Tech Market Attractiveness Index
  • Figure 114 MEA Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 115 MEA Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 116 MEA Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 117 MEA Female Health Tech Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 118 MEA Female Health Tech Market Share Forecast by Product Type, 2024 & 2034 (%)
  • Figure 119 MEA Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 120 MEA Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 121 GCC Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 122 South Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 123 Rest of MEA Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 124 Female Health Tech Company Share, 2022
  • Figure 125 HeraMed Ltd.: Net Revenue, 2018-2022 (US$ Million, AGR%)
  • Figure 126 HeraMed Ltd.: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 127 Minerva Surgical, Inc.: Net Revenue, 2017-2023 (US$ Million, AGR%)
  • Figure 128 Minerva Surgical, Inc.: R&D, 2020-2022 (US$ Million, AGR%)
  • Figure 129 Sera Prognostics: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 130 Sera Prognostics: R&D, 2017-2022 (US$ Million, AGR%)
目次
Product Code: PHA1328

The global Female Health Tech market is estimated to grow at a CAGR of 9.6% by 2034

The Female Health Tech Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increased Awareness and Focus on Women's Health

Increased awareness and focus on women's health have been transformative, driven by a confluence of factors that have brought long-overdue attention to the unique healthcare needs of women. Historically, women's health issues were often overlooked or generalized within the broader context of healthcare. However, concerted efforts from healthcare professionals, researchers, advocacy groups, and policymakers have reshaped this landscape. Research initiatives have delved into conditions specific to women, unravelling the complexities of reproductive health, hormonal fluctuations, and diseases like endometriosis and polycystic ovary syndrome (PCOS). Simultaneously, educational campaigns have sought to dismantle taboos surrounding women's health, fostering open dialogues and empowering women to advocate for their own well-being. Public health campaigns have spotlighted critical issues such as maternal mortality rates, breast cancer awareness, and access to contraception, amplifying the urgency for targeted interventions. Moreover, advocacy movements have catalyzed policy changes, leading to greater recognition of women's health as a fundamental aspect of public health agendas. This heightened awareness has not only fostered a more inclusive approach to healthcare but has also driven innovation in female health technology, with solutions ranging from wearable devices for menstrual tracking to AI-powered platforms for personalized health insights. Overall, the increased awareness and focus on women's health signify a pivotal shift towards equitable healthcare provision and a deeper understanding of the diverse needs of women across the lifespan.

Technological advancements in patient care

Technological advancements in female health tech have revolutionized the landscape of women's healthcare, offering innovative solutions tailored to address the unique needs and experiences of women. These advancements span a wide range of areas, from reproductive health to menopause management, and have been made possible by breakthroughs in various fields of technology.

Wearable devices, such as smartwatches and fitness trackers, have emerged as powerful tools for women to monitor their menstrual cycles, track fertility windows, and manage overall health and wellness. These devices leverage sensors and algorithms to collect data on physiological parameters, providing users with valuable insights into their reproductive health and helping them make informed decisions about contraception, fertility planning, and menstrual cycle management.

Mobile applications have also played a crucial role in empowering women to take control of their health. These apps offer a diverse array of features, including menstrual tracking, ovulation prediction, pregnancy monitoring, and symptom management for conditions like endometriosis and PCOS. By digitizing health information and providing personalized recommendations, these apps enable women to actively participate in managing their health and well-being.

Telemedicine platforms have expanded access to healthcare services for women, particularly in underserved areas or for individuals with mobility constraints. These platforms facilitate remote consultations with healthcare providers, enabling women to seek advice, receive diagnoses, and access treatments from the comfort of their homes. This has proven especially valuable during the COVID-19 pandemic, when in-person healthcare services were limited.

What Questions Should You Ask before Buying a Market Research Report?

How is the Female Health Tech Market evolving?

What is driving and restraining the Female Health Tech Market?

How will each Female Health Tech submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each Female Health Tech submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading Female Health Tech Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the Female Health Tech projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of Female Health

Tech projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the Female Health Tech Market?

Where is the Female Health Tech Market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Female Health Tech Market today, and over the next 10 years:

Our 284-page report provides 101 tables and 130 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Female Health Tech Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Female Health Tech prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

By Product Types

Consumer Products

Devices (Wearables, Hardware)

Software (Apps)

Diagnostics

Digital Platform

Drugs, Vitamins & Supplements

Services

Telehealth

By Application

Pregnancy and Nursing Care

Reproductive Health and Contraception

Menstrual Health

General Healthcare

Pelvic and Uterine Healthcare

Sexual Health

Women's Wellness

Menopause Care

Longevity

Mental Health

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 25 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Spain

Italy

Poland

Belgium

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Singapore

Taiwan

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Female Health Tech Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

Athena Feminine Technologies

Bloomlife

Elvie (Chiaro Technology Limited)

HeraMED

iSono Health

Minerva Surgical

NUVO Inc

Prelude Fertility, Inc.

Sera Prognostics

Univfy Inc.

TOTOHEALTH LIMITED

Overall world revenue for Female Health Tech Market, 2024 to 2034 in terms of value the market will surpass US$ 140.9 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Female Health Tech Market, 2024 to 2034 report help you?

In summary, our 280+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Female Health Tech Market, 2024 to 2034 Market, with forecasts for material, design, type, delivery and application, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 27 key national markets - See forecasts for the Female Health Tech Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 11 of the major companies involved in the Female Health Tech Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Female Health Tech Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Female Health Tech Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increasing Awareness and Education
      • 3.2.1.2 Rapid Advancements in Technology are Catalysing the Growth of the Female Health Tech Market
      • 3.2.1.3 Increasing Empowerment and Advocacy for Women's Health and Wellness
      • 3.2.1.4 Healthcare Personalization is a Key Driving Force Behind the Growth of the Female Health Tech
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Complex Regulatory Frameworks and Varying Standards for Healthcare Technologies Across Different Region
      • 3.2.2.2 Privacy and Security Risks Associated with the Collection, Storage, and Transmission of Sensitive Health Data
      • 3.2.2.3 Healthcare Inequities and Disparities in Access to Healthcare Services, Particularly in Underserved Regions and Marginalized Communities
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Development of New Products and Services that Address Unmet Needs in Women's Health
      • 3.2.3.2 Partnerships Between Healthcare Providers, Technology Companies, and Research Institutions
      • 3.2.3.3 Global Health Initiatives Aimed at Improving Women's Health Outcomes
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Female Health Tech Market Analysis by Product Type

  • 4.1 Key Findings
  • 4.2 Application Segment: Market Attractiveness Index
  • 4.3 Female Health Tech Market Size Estimation and Forecast by Product Types
  • 4.4 Consumer Products
    • 4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Devices (Wearables, hardware)
    • 4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 Software (Apps)
    • 4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Diagnostics
    • 4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)
  • 4.8 Digital Platform
    • 4.8.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.8.2 Market Share by Region, 2024 & 2034 (%)
  • 4.9 Drugs, Vitamins & Supplements
    • 4.9.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.9.2 Market Share by Region, 2024 & 2034 (%)
  • 4.10 Services
    • 4.10.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.10.2 Market Share by Region, 2024 & 2034 (%)
  • 4.11 Telehealth
    • 4.11.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.11.2 Market Share by Region, 2024 & 2034 (%)

5 Female Health Tech Market Analysis by Application

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 Female Health Tech Market Size Estimation and Forecast by Application
  • 5.4 Pregnancy and Nursing Care
    • 5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Reproductive Health and Contraception
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Menstrual Health
    • 5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 General Healthcare
    • 5.7.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)
  • 5.8 Pelvic and Uterine Healthcare
    • 5.8.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.8.2 Market Share by Region, 2024 & 2034 (%)
  • 5.9 Sexual Health
    • 5.9.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.9.2 Market Share by Region, 2024 & 2034 (%)
  • 5.10 Women's Wellness
    • 5.10.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.10.2 Market Share by Region, 2024 & 2034 (%)
  • 5.11 Menopause Care
    • 5.11.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.11.2 Market Share by Region, 2024 & 2034 (%)
  • 5.12 Longevity
    • 5.12.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.12.2 Market Share by Region, 2024 & 2034 (%)
  • 5.13 Mental Health
    • 5.13.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.13.2 Market Share by Region, 2024 & 2034 (%)

6 Female Health Tech Market Analysis by Region

  • 6.1 Key Findings
  • 6.2 Regional Market Size Estimation and Forecast

7 North America Female Health Tech Market Analysis

  • 7.1 Key Findings
  • 7.2 North America Female Health Tech Market Attractiveness Index
  • 7.3 North America Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 7.4 North America Female Health Tech Market Size Estimation and Forecast by Country
  • 7.5 North America Female Health Tech Market Size Estimation and Forecast by Product Type
  • 7.6 North America Female Health Tech Market Size Estimation and Forecast by Application
  • 7.7 U.S. Female Health Tech Market Analysis
  • 7.8 Canada Female Health Tech Market Analysis

8 Europe Female Health Tech Market Analysis

  • 8.1 Key Findings
  • 8.2 Europe Female Health Tech Market Attractiveness Index
  • 8.3 Europe Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 8.4 Europe Female Health Tech Market Size Estimation and Forecast by Country
  • 8.5 Europe Female Health Tech Market Size Estimation and Forecast by Product Type
  • 8.6 Europe Female Health Tech Market Size Estimation and Forecast by Application
  • 8.7 Germany Female Health Tech Market Analysis
  • 8.8 France Female Health Tech Market Analysis
  • 8.9 UK Female Health Tech Market Analysis
  • 8.10 Italy Female Health Tech Market Analysis
  • 8.11 Spain Female Health Tech Market Analysis
  • 8.12 Russia Female Health Tech Market Analysis
  • 8.13 Poland Female Health Tech Market Analysis
  • 8.14 Belgium Female Health Tech Market Analysis
  • 8.15 Rest of Europe Female Health Tech Market Analysis

9 Asia Pacific Female Health Tech Market Analysis

  • 9.1 Key Findings
  • 9.2 Asia Pacific Female Health Tech Market Attractiveness Index
  • 9.3 Asia Pacific Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 9.4 Asia Pacific Female Health Tech Market Size Estimation and Forecast by Country
  • 9.5 Asia Pacific Female Health Tech Market Size Estimation and Forecast by Product Type
  • 9.6 Asia Pacific Female Health Tech Market Size Estimation and Forecast by Application
  • 9.7 Japan Female Health Tech Market Analysis
  • 9.8 China Female Health Tech Market Analysis
  • 9.9 India Female Health Tech Market Analysis
  • 9.10 Australia Female Health Tech Market Analysis
  • 9.11 South Korea Female Health Tech Market Analysis
  • 9.12 Singapore Female Health Tech Market Analysis
  • 9.13 Taiwan Female Health Tech Market Analysis
  • 9.14 Rest of Asia Pacific Female Health Tech Market Analysis

10 Latin America Female Health Tech Market Analysis

  • 10.1 Key Findings
  • 10.2 Latin America Female Health Tech Market Attractiveness Index
  • 10.3 Latin America Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 10.4 Latin America Female Health Tech Market Size Estimation and Forecast by Country
  • 10.5 Latin America Female Health Tech Market Size Estimation and Forecast by Product Type
  • 10.6 Latin America Female Health Tech Market Size Estimation and Forecast by Application
  • 10.7 Brazil Female Health Tech Market Analysis
  • 10.8 Mexico Female Health Tech Market Analysis
  • 10.9 Argentina Female Health Tech Market Analysis
  • 10.10 Colombia Female Health Tech Market Analysis
  • 10.11 Rest of Latin America Female Health Tech Market Analysis

11 MEA Female Health Tech Market Analysis

  • 11.1 Key Findings
  • 11.2 MEA Female Health Tech Market Attractiveness Index
  • 11.3 MEA Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 11.4 MEA Female Health Tech Market Size Estimation and Forecast by Country
  • 11.5 MEA Female Health Tech Market Size Estimation and Forecast by Product Type
  • 11.6 MEA Female Health Tech Market Size Estimation and Forecast by Application
  • 11.7 GCC Female Health Tech Market Analysis
  • 11.8 South Africa Female Health Tech Market Analysis
  • 11.9 Rest of MEA Female Health Tech Market Analysis

12 Company Profiles

  • 12.1 Competitive Landscape, 2022
  • 12.2 Summary of all Strategic Outlook
  • 12.3 Athena Feminine Technologies, Inc.
    • 12.3.1 Company Snapshot
    • 12.3.2 Company Overview
    • 12.3.3 Product Benchmarking
    • 12.3.4 Strategic Outlook
  • 12.4 Bloomlife, Inc.
    • 12.4.1 Company Snapshot
    • 12.4.2 Company Overview
    • 12.4.3 Product Benchmarking
    • 12.4.4 Strategic Outlook
  • 12.5 Elvie (Chiaro Technology Limited)
    • 12.5.1 Company Snapshot
    • 12.5.2 Company Overview
    • 12.5.3 Product Benchmarking
    • 12.5.4 Strategic Outlook
  • 12.6 HeraMed Ltd
    • 12.6.1 Company Snapshot
    • 12.6.2 Company Overview
    • 12.6.3 Financial Analysis
      • 12.6.3.1 Net Revenue, 2018-2022
      • 12.6.3.2 R&D, 2017-2022
    • 12.6.4 Product Benchmarking
    • 12.6.5 Strategic Outlook
  • 12.7 iSono Health, Inc.
    • 12.7.1 Company Snapshot
    • 12.7.2 Company Overview
    • 12.7.3 Product Benchmarking
    • 12.7.4 Strategic Outlook
  • 12.8 Minerva Surgical, Inc.
    • 12.8.1 Company Snapshot
    • 12.8.2 Company Overview
    • 12.8.3 Financial Analysis
      • 12.8.3.1 Net Revenue, 2020-2022
      • 12.8.3.2 R&D, 2020-2022
    • 12.8.4 Product Benchmarking
    • 12.8.5 Strategic Outlook
  • 12.9 Nuvo, Inc.
    • 12.9.1 Company Snapshot
    • 12.9.2 Company Overview
    • 12.9.3 Product Benchmarking
    • 12.9.4 Strategic Outlook
  • 12.10 Prelude Fertility, Inc.
    • 12.10.1 Company Snapshot
    • 12.10.2 Company Overview
    • 12.10.3 Product Benchmarking
    • 12.10.4 Strategic Outlook
  • 12.11 Sera Prognostics
    • 12.11.1 Company Snapshot
    • 12.11.2 Company Overview
    • 12.11.3 Financial Analysis
      • 12.11.3.1 Net Revenue, 2017-2022
      • 12.11.3.2 R&D, 2017-2022
    • 12.11.4 Product Benchmarking
    • 12.11.5 Strategic Outlook
  • 12.12 Univfy, Inc.
    • 12.12.1 Company Snapshot
    • 12.12.2 Company Overview
    • 12.12.3 Product Benchmarking
    • 12.12.4 Strategic Outlook
  • 12.13 Totohealth Limited
    • 12.13.1 Company Snapshot
    • 12.13.2 Company Overview
    • 12.13.3 Product Benchmarking

13 Conclusion and Recommendations

  • 13.1 Concluding Remarks from Visiongain
  • 13.2 Recommendations for Market Players